Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

June 1, 2028

Conditions
Schizophrenia
Interventions
DRUG

Atorvastatin

Participants will receive atorvastatin 20 mg daily.

DRUG

Metformin

Participants will receive metformin 1000 mg daily.

DRUG

Placebo

Participants will receive placebo 1000 mg daily, mimicking the appearance of metformin without containing active ingredients.

Trial Locations (6)

315799

NOT_YET_RECRUITING

Xiangshan County Traditional Chinese Medicine Hospital Medical and Health Group Three Hospitals District, Xiangshan

417000

NOT_YET_RECRUITING

Loudi Rehabilitation Hospital, Loudi Mental Health Center, Loudi

Unknown

NOT_YET_RECRUITING

Zhumadian Second People's Hospital, Zhumadian

RECRUITING

Mental Health Institute of Second Xiangya Hospital, CSU, Changsha

RECRUITING

The Third Hospital of Changsha County, Changsha

NOT_YET_RECRUITING

The Second People's Hospital of Dali Bai Autonomous Prefecture, Dali

All Listed Sponsors
collaborator

Zhumadian Second People's Hospital

UNKNOWN

collaborator

The Third Hospital of Changsha County

UNKNOWN

collaborator

The Second People's Hospital of Dali Bai Autonomous Prefecture

UNKNOWN

collaborator

Xiangshan County Traditional Chinese Medicine Hospital Medical and Health Group Three Hospitals Distric

UNKNOWN

collaborator

Loudi Rehabilitation Hospital, Loudi Mental Health Center

UNKNOWN

lead

Central South University

OTHER